Frontlight ResearchEarly access
Trial site
Levine Cancer Institute Concord
- 2running trials
- 1closed trial
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer1 trial
- Follicular lymphoma1 trial
- Multiple myeloma1 trial
- Phase
- Phase 1/21 trial
- Phase 21 trial
- Phase 31 trial
- Status
- Active, not recruiting1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Epizyme, Inc.1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
- Teva Branded Pharmaceutical Products R&D LLC1 trial
Running trials
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026